{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:07:31Z","timestamp":1790244451657,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002014"],"award-info":[{"award-number":["UL1 TR002014"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR00045"],"award-info":[{"award-number":["UL1 TR00045"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019874","name":"Children's Hospital Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacapopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAACAP Open"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaacop.2026.05.005","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:14:20Z","timestamp":1780449260000},"page":"809-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Patterns and Clinical Outcomes in Youth With Attention-Deficit\/Hyperactivity Disorder and Autism Spectrum Disorder"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0492-0643","authenticated-orcid":false,"given":"Raman","family":"Baweja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8115-1286","authenticated-orcid":false,"given":"Daniel A.","family":"Waschbusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1689-1085","authenticated-orcid":false,"given":"Narpinder","family":"Malhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8153-8213","authenticated-orcid":false,"given":"Margaret D.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6643-5125","authenticated-orcid":false,"given":"Michael","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5563-3417","authenticated-orcid":false,"given":"James G.","family":"Waxmonsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaacop.2026.05.005_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","article-title":"The World Federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder","volume":"128","author":"Faraone","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"10.1016\/j.jaacop.2026.05.005_bib2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/aur.2696","article-title":"Global prevalence of autism: a systematic review update","volume":"15","author":"Zeidan","year":"2022","journal-title":"Autism Res"},{"key":"10.1016\/j.jaacop.2026.05.005_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105436","article-title":"Prevalence of co-occurring conditions in children and adults with autism spectrum disorder: a systematic review and meta-analysis","volume":"155","author":"Micai","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"issue":"13","key":"10.1016\/j.jaacop.2026.05.005_bib4","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1017\/S0033291719002368","article-title":"Autistic spectrum disorder symptoms in children and adolescents with attention-deficit\/hyperactivity disorder: a meta-analytical review","volume":"50","author":"Hollingdale","year":"2020","journal-title":"Psychol Med"},{"issue":"5","key":"10.1016\/j.jaacop.2026.05.005_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11920-019-1020-5","article-title":"Autism spectrum disorders and ADHD: overlapping phenomenology, diagnostic issues, and treatment considerations","volume":"21","author":"Antshel","year":"2019","journal-title":"Curr Psychiatry Rep"},{"issue":"10","key":"10.1016\/j.jaacop.2026.05.005_bib6","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41588-022-01171-3","article-title":"Identification of shared and differentiating genetic architecture for autism spectrum disorder, attention-deficit hyperactivity disorder and case subgroups","volume":"54","author":"Mattheisen","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaacop.2026.05.005_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neubiorev.2016.03.019","article-title":"Autism spectrum disorder and attention-deficit\/hyperactivity disorder in early childhood: a review of unique and shared characteristics and developmental antecedents","volume":"65","author":"Visser","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"10.1016\/j.jaacop.2026.05.005_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/aur.2894","article-title":"Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit\/hyperactivity disorder: a population-based study","volume":"16","author":"Casseus","year":"2023","journal-title":"Autism Res"},{"key":"10.1016\/j.jaacop.2026.05.005_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.914668","article-title":"Understanding the diversity of pharmacotherapeutic management of ADHD with co-occurring autism: an Australian cross-sectional survey","volume":"13","author":"Mellahn","year":"2022","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.jaacop.2026.05.005_bib10","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1186\/s12913-025-13296-2","article-title":"Real-world evaluation of prevalence, cohort characteristics, and health care use and expenditures among adults and children with autism spectrum disorder, attention-deficit hyperactivity disorder, or both","volume":"25","author":"Zaleski","year":"2025","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jaacop.2026.05.005_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neubiorev.2019.05.022","article-title":"Association between suicidal spectrum behaviors and attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"103","author":"Septier","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"issue":"9","key":"10.1016\/j.jaacop.2026.05.005_bib12","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1017\/S0033291719001405","article-title":"Individual risk and familial liability for suicide attempt and suicide in autism: a population-based study","volume":"50","author":"Hirvikoski","year":"2020","journal-title":"Psychol Med"},{"issue":"1","key":"10.1016\/j.jaacop.2026.05.005_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1027\/0227-5910\/a000284","article-title":"Suicide ideation and attempts in children with psychiatric disorders and typical development","volume":"36","author":"Dickerson Mayes","year":"2015","journal-title":"Crisis"},{"issue":"7","key":"10.1016\/j.jaacop.2026.05.005_bib14","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder","volume":"46","author":"Pliszka","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9","key":"10.1016\/j.jaacop.2026.05.005_bib15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.jaacop.2026.05.005_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/jcpp.13305","article-title":"Practitioner review: pharmacological treatment of attention-deficit\/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis","volume":"62","author":"Rodrigues","year":"2021","journal-title":"J Child Psychol Psychiatry"},{"issue":"3","key":"10.1016\/j.jaacop.2026.05.005_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaac.2022.05.012","article-title":"Systematic review and meta-analysis: pharmacological and nonpharmacological interventions for persistent nonepisodic irritability","volume":"62","author":"Breaux","year":"2023","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"10.1016\/j.jaacop.2026.05.005_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archpsyc.62.11.1266","article-title":"Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity","volume":"62","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jaacop.2026.05.005_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110326","article-title":"The pediatric psychopharmacology of autism spectrum disorder: a systematic review\u2014part I: the past and the present","volume":"110","author":"Persico","year":"2021","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.jaacop.2026.05.005_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/aur.2059","article-title":"Atomoxetine for attention deficit hyperactivity disorder in children and adolescents with autism: a systematic review and meta-analysis","volume":"12","author":"Patra","year":"2019","journal-title":"Autism Res"},{"issue":"11","key":"10.1016\/j.jaacop.2026.05.005_bib21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jaac.2015.08.013","article-title":"Atomoxetine, parent training, and their combination in children with autism spectrum disorder and attention-deficit\/hyperactivity disorder","volume":"54","author":"Handen","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"10.1016\/j.jaacop.2026.05.005_bib22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jaac.2012.04.011","article-title":"A randomized double-blind study of atomoxetine versus placebo for attention-deficit\/hyperactivity disorder symptoms in children with autism spectrum disorder","volume":"51","author":"Harfterkamp","year":"2012","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"10.1016\/j.jaacop.2026.05.005_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14114000","article-title":"Children and adolescents with co-occurring attention-deficit\/hyperactivity disorder and autism spectrum disorder: a systematic review of multimodal interventions","volume":"14","author":"De Domenico","year":"2025","journal-title":"J Clin Med"},{"issue":"20","key":"10.1016\/j.jaacop.2026.05.005_bib24","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1001\/jama.2021.6118","article-title":"\u03b12-Adrenergic agonists or stimulants for preschool-age children with attention-deficit\/hyperactivity disorder","volume":"325","author":"Harstad","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jaacop.2026.05.005_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.10999","article-title":"Treatment of US children with attention-deficit\/hyperactivity disorder in the Adolescent Brain Cognitive Development Study","volume":"6","author":"Olfson","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.jaacop.2026.05.005_bib26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/cap.2021.0017","article-title":"Psychotropic medication prescribing for youth at a regional autism center","volume":"31","author":"Gannon","year":"2021","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"10.1016\/j.jaacop.2026.05.005_bib27","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1097\/DBP.0000000000001296","article-title":"Trends in pediatric attention-deficit hyperactive disorder diagnoses and prescription use: 2016 to 2019","volume":"45","author":"Kazarov","year":"2024","journal-title":"J Dev Behav Pediatr"},{"issue":"5","key":"10.1016\/j.jaacop.2026.05.005_bib28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/DBP.0000000000001044","article-title":"Psychotropic medication use by children with autism served in publicly funded mental health settings","volume":"43","author":"Caplan","year":"2022","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.jaacop.2026.05.005_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2025.114471","article-title":"Pediatric attention-deficit\/hypearativity disorder and disruptive mood dysregulation disorder: analyzing national treatment trends","author":"Baweja","year":"2025","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jaacop.2026.05.005_bib30","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/sim.6004","article-title":"A comparison of 12 algorithms for matching on the propensity score","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"issue":"9","key":"10.1016\/j.jaacop.2026.05.005_bib31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.30773\/pi.2022.0117","article-title":"Effectiveness of clonidine in child and adolescent sleep disorders","volume":"19","author":"Jang","year":"2022","journal-title":"Psychiatry Investig"},{"issue":"11","key":"10.1016\/j.jaacop.2026.05.005_bib32","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1007\/s12325-024-02980-0","article-title":"Efficacy and safety of alpha-2 agonists in autism spectrum disorder: a systematic review","volume":"41","author":"Kaye","year":"2024","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.jaacop.2026.05.005_bib33","first-page":"144","article-title":"Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents","volume":"10","author":"Wolraich","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaacop.2026.05.005_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111089","article-title":"Effectiveness of pharmacological interventions for managing ADHD symptoms in individuals with autism spectrum disorder: a systematic review and meta-analysis","volume":"134","author":"Martins","year":"2024","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.jaacop.2026.05.005_bib35","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.3390\/jcm9082566","article-title":"Methylphenidate in autism spectrum disorder: a long-term follow up naturalistic study","volume":"9","author":"Ventura","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.jaacop.2026.05.005_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.2859","article-title":"Attention-deficit\/hyperactivity disorder medications and work disability and mental health outcomes","volume":"7","author":"Taipale","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jaacop.2026.05.005_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41398-024-02825-y","article-title":"ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study","volume":"14","author":"Vasiliadis","year":"2024","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jaacop.2026.05.005_bib38","article-title":"Systematic review: safety and efficacy of atomoxetine in children and adolescents with autism spectrum disorder","author":"Gupta","year":"2025","journal-title":"JCPP Adv"},{"issue":"12","key":"10.1016\/j.jaacop.2026.05.005_bib39","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1176\/appi.ajp.2015.15010055","article-title":"Extended-release guanfacine for hyperactivity in children with autism spectrum disorder","volume":"172","author":"Scahill","year":"2015","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.jaacop.2026.05.005_bib40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1176\/appi.ajp.2007.05091676","article-title":"Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response","volume":"165","author":"Newcorn","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaacop.2026.05.005_bib41","first-page":"1085","article-title":"Guanfacine extended release for children and adolescents with attention-deficit\/hyperactivity disorder: efficacy following prior methylphenidate treatment","author":"Huss","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"10.1016\/j.jaacop.2026.05.005_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaac.2022.03.033","article-title":"Systematic review and meta-analysis: efficacy of pharmacological interventions for irritability and emotional dysregulation in autism spectrum disorder and predictors of response","volume":"62","author":"de Pablo","year":"2023","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.jaacop.2026.05.005_bib43","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamapsychiatry.2023.4573","article-title":"Antipsychotic medications and mortality in children and young adults","volume":"81","author":"Ray","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.jaacop.2026.05.005_bib44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/wps.20765","article-title":"Safety of 80 antidepressants, antipsychotics, anti-attention-deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects","volume":"19","author":"Solmi","year":"2020","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1016\/j.jaacop.2026.05.005_bib45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.chc.2022.02.003","article-title":"Updates in pharmacologic strategies for emotional dysregulation in attention deficit hyperactivity disorder","volume":"31","author":"Baweja","year":"2022","journal-title":"Child Adolesc Psychiatr Clinics"},{"issue":"4","key":"10.1016\/j.jaacop.2026.05.005_bib46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/cap.2008.0137","article-title":"Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit\/hyperactivity disorder symptoms in preschoolers with developmental disorders","volume":"19","author":"Ghuman","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"11","key":"10.1016\/j.jaacop.2026.05.005_bib47","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.chi.0000235077.32661.61","article-title":"Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD","volume":"45","author":"Greenhill","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9","key":"10.1016\/j.jaacop.2026.05.005_bib48","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1176\/appi.ps.201100318","article-title":"Pediatric psychopharmacology: context, model programs, and considerations for care","volume":"63","author":"Pidano","year":"2012","journal-title":"Psychiatr Serv"},{"issue":"12","key":"10.1016\/j.jaacop.2026.05.005_bib49","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.5498\/wjp.v11.i12.1206","article-title":"Review of barriers and interventions to promote treatment engagement for pediatric attention deficit hyperactivity disorder care","volume":"11","author":"Baweja","year":"2021","journal-title":"World J Psychiatry"},{"issue":"23","key":"10.1016\/j.jaacop.2026.05.005_bib50","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1001\/jama.2021.17579","article-title":"Addressing racism in preventive services: methods report to support the US Preventive Services Task Force","volume":"326","author":"Lin","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jaacop.2026.05.005_bib51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/cap.2020.0110","article-title":"Psychotropic polypharmacy among children and youth with autism: a systematic review","volume":"31","author":"Ritter","year":"2021","journal-title":"J Child Adolesc Psychopharmacol"}],"container-title":["JAACAP Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949732926000566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949732926000566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:22:45Z","timestamp":1790241765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949732926000566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2949732926000566"],"URL":"https:\/\/doi.org\/10.1016\/j.jaacop.2026.05.005","relation":{},"ISSN":["2949-7329"],"issn-type":[{"value":"2949-7329","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Patterns and Clinical Outcomes in Youth With Attention-Deficit\/Hyperactivity Disorder and Autism Spectrum Disorder","name":"articletitle","label":"Article Title"},{"value":"JAACAP Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaacop.2026.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Academy of Child & Adolescent Psychiatry.","name":"copyright","label":"Copyright"}]}}